Approvals/TGA/ERBITUX cetuximab (rmc) 100mg/20mL solution for intravenous infusion

Approved

STANDARD

ERBITUX cetuximab (rmc) 100mg/20mL solution for intravenous infusion

Merck Healthcare Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 2ddcd9183ab21444
Product Name: ERBITUX cetuximab (rmc) 100mg/20mL solution for intravenous infusion
Artg Id: 132393
Artg Name: ERBITUX cetuximab (rmc) 100mg/20mL solution for intravenous infusion
Sponsor: Merck Healthcare Pty Ltd
Company Detail Path: /organization/merck-healthcare-pty-ltd
Artg Date: 2007-09-25
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-CMI-01424-3
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-PI-01421-3

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

2ddcd9183ab21444

Type

Standard